Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230227057548N1Phase 3Completed
Phase 3 trial of lidocaine in cholelithiasis, sponsored by Ilam University of Medical Sciences. Primary endpoint: Extubation side effects by age group with lidocaine use. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230227057548N1.